Henry Schein, Inc. (0L3C.L)
USD 72.28
(-1.94%)
USD 72.28
(-1.94%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 10.57 Billion USD | 22.84% |
| 2022 | 8.6 Billion USD | 1.48% |
| 2021 | 8.48 Billion USD | 9.12% |
| 2020 | 7.77 Billion USD | 8.69% |
| 2019 | 7.15 Billion USD | -15.87% |
| 2018 | 8.5 Billion USD | 8.82% |
| 2017 | 7.81 Billion USD | 16.06% |
| 2016 | 6.73 Billion USD | 3.47% |
| 2015 | 6.5 Billion USD | 5.96% |
| 2014 | 6.13 Billion USD | 9.14% |
| 2013 | 5.62 Billion USD | 5.45% |
| 2012 | 5.33 Billion USD | 12.53% |
| 2011 | 4.74 Billion USD | 4.24% |
| 2010 | 4.54 Billion USD | 18.55% |
| 2009 | 3.83 Billion USD | 6.57% |
| 2008 | 3.59 Billion USD | 8.62% |
| 2007 | 3.31 Billion USD | 15.02% |
| 2006 | 2.88 Billion USD | 11.54% |
| 2005 | 2.58 Billion USD | 6.14% |
| 2004 | 2.43 Billion USD | 33.76% |
| 2003 | 1.81 Billion USD | 16.77% |
| 2002 | 1.55 Billion USD | 12.46% |
| 2001 | 1.38 Billion USD | 12.54% |
| 2000 | 1.23 Billion USD | 2.24% |
| 1999 | 1.2 Billion USD | 25.17% |
| 1998 | 962 Million USD | 29.79% |
| 1997 | 741.2 Million USD | 59.78% |
| 1996 | 463.9 Million USD | 56.25% |
| 1995 | 296.9 Million USD | 56.26% |
| 1994 | 190 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 10.25 Billion USD | 1.04% |
| 2024 Q1 | 10.14 Billion USD | -4.05% |
| 2023 Q1 | 8.57 Billion USD | -0.41% |
| 2023 Q3 | 9.81 Billion USD | 7.26% |
| 2023 Q2 | 9.14 Billion USD | 6.7% |
| 2023 FY | 10.57 Billion USD | 22.84% |
| 2023 Q4 | 10.57 Billion USD | 7.78% |
| 2022 Q2 | 8.32 Billion USD | -1.46% |
| 2022 Q1 | 8.44 Billion USD | -0.4% |
| 2022 FY | 8.6 Billion USD | 1.48% |
| 2022 Q4 | 8.6 Billion USD | 0.86% |
| 2022 Q3 | 8.53 Billion USD | 2.52% |
| 2021 Q3 | 8.42 Billion USD | 3.65% |
| 2021 FY | 8.48 Billion USD | 9.12% |
| 2021 Q1 | 7.77 Billion USD | 0.1% |
| 2021 Q2 | 8.12 Billion USD | 4.42% |
| 2021 Q4 | 8.48 Billion USD | 0.72% |
| 2020 Q1 | 7.51 Billion USD | 5.15% |
| 2020 Q2 | 7.31 Billion USD | -2.67% |
| 2020 Q3 | 7.8 Billion USD | 6.72% |
| 2020 Q4 | 7.77 Billion USD | -0.48% |
| 2020 FY | 7.77 Billion USD | 8.69% |
| 2019 Q1 | 7.14 Billion USD | -15.95% |
| 2019 FY | 7.15 Billion USD | -15.87% |
| 2019 Q2 | 7.11 Billion USD | -0.46% |
| 2019 Q3 | 7.09 Billion USD | -0.21% |
| 2019 Q4 | 7.15 Billion USD | 0.76% |
| 2018 Q3 | 8.39 Billion USD | 7.43% |
| 2018 Q2 | 7.8 Billion USD | -1.33% |
| 2018 Q1 | 7.91 Billion USD | 1.33% |
| 2018 FY | 8.5 Billion USD | 8.82% |
| 2018 Q4 | 8.5 Billion USD | 1.31% |
| 2017 Q1 | 6.84 Billion USD | 1.7% |
| 2017 FY | 7.81 Billion USD | 16.06% |
| 2017 Q4 | 7.81 Billion USD | 4.34% |
| 2017 Q3 | 7.48 Billion USD | 5.48% |
| 2017 Q2 | 7.09 Billion USD | 3.69% |
| 2016 Q4 | 6.73 Billion USD | 1.46% |
| 2016 Q2 | 6.63 Billion USD | 0.5% |
| 2016 Q1 | 6.6 Billion USD | 1.47% |
| 2016 FY | 6.73 Billion USD | 3.47% |
| 2016 Q3 | 6.63 Billion USD | -0.0% |
| 2015 Q4 | 6.5 Billion USD | 2.09% |
| 2015 FY | 6.5 Billion USD | 5.96% |
| 2015 Q3 | 6.37 Billion USD | 4.36% |
| 2015 Q2 | 6.1 Billion USD | 2.8% |
| 2015 Q1 | 5.93 Billion USD | -3.25% |
| 2014 Q2 | 5.99 Billion USD | 1.9% |
| 2014 Q3 | 6.13 Billion USD | 2.32% |
| 2014 Q4 | 6.13 Billion USD | 0.13% |
| 2014 Q1 | 5.88 Billion USD | 4.54% |
| 2014 FY | 6.13 Billion USD | 9.14% |
| 2013 FY | 5.62 Billion USD | 5.45% |
| 2013 Q4 | 5.62 Billion USD | 6.57% |
| 2013 Q3 | 5.27 Billion USD | 2.2% |
| 2013 Q2 | 5.16 Billion USD | -0.79% |
| 2013 Q1 | 5.2 Billion USD | -2.41% |
| 2012 Q1 | 4.75 Billion USD | 0.41% |
| 2012 Q3 | 5.11 Billion USD | 5.71% |
| 2012 Q2 | 4.83 Billion USD | 1.59% |
| 2012 FY | 5.33 Billion USD | 12.53% |
| 2012 Q4 | 5.33 Billion USD | 4.35% |
| 2011 Q2 | 4.88 Billion USD | 1.85% |
| 2011 FY | 4.74 Billion USD | 4.24% |
| 2011 Q4 | 4.74 Billion USD | -1.21% |
| 2011 Q3 | 4.79 Billion USD | -1.75% |
| 2011 Q1 | 4.79 Billion USD | 5.44% |
| 2010 Q2 | 4.41 Billion USD | 3.64% |
| 2010 FY | 4.54 Billion USD | 18.55% |
| 2010 Q1 | 4.26 Billion USD | 11.12% |
| 2010 Q4 | 4.54 Billion USD | -1.24% |
| 2010 Q3 | 4.6 Billion USD | 4.23% |
| 2009 FY | 3.83 Billion USD | 6.57% |
| 2009 Q2 | 3.64 Billion USD | 6.2% |
| 2009 Q3 | 3.7 Billion USD | 1.59% |
| 2009 Q4 | 3.83 Billion USD | 3.58% |
| 2009 Q1 | 3.43 Billion USD | -4.64% |
| 2008 FY | 3.59 Billion USD | 8.62% |
| 2008 Q4 | 3.59 Billion USD | 2.65% |
| 2008 Q1 | 3.38 Billion USD | 2.25% |
| 2008 Q2 | 3.46 Billion USD | 2.39% |
| 2008 Q3 | 3.5 Billion USD | 1.07% |
| 2007 Q3 | 3.28 Billion USD | 13.35% |
| 2007 FY | 3.31 Billion USD | 15.02% |
| 2007 Q1 | 2.81 Billion USD | -2.28% |
| 2007 Q2 | 2.89 Billion USD | 2.89% |
| 2007 Q4 | 3.31 Billion USD | 0.93% |
| 2006 Q4 | 2.88 Billion USD | 6.02% |
| 2006 FY | 2.88 Billion USD | 11.54% |
| 2006 Q3 | 2.71 Billion USD | 2.55% |
| 2006 Q2 | 2.65 Billion USD | 3.24% |
| 2006 Q1 | 2.56 Billion USD | -0.63% |
| 2005 FY | 2.58 Billion USD | 6.14% |
| 2005 Q2 | 2.43 Billion USD | 4.26% |
| 2005 Q3 | 2.48 Billion USD | 1.71% |
| 2005 Q4 | 2.58 Billion USD | 4.09% |
| 2005 Q1 | 2.34 Billion USD | -3.84% |
| 2004 Q2 | 2.2 Billion USD | 20.06% |
| 2004 Q4 | 2.43 Billion USD | 10.01% |
| 2004 Q3 | 2.21 Billion USD | 0.55% |
| 2004 Q1 | 1.83 Billion USD | 0.73% |
| 2004 FY | 2.43 Billion USD | 33.76% |
| 2003 FY | 1.81 Billion USD | 16.77% |
| 2003 Q4 | 1.81 Billion USD | 7.21% |
| 2003 Q3 | 1.69 Billion USD | 5.15% |
| 2003 Q1 | 1.55 Billion USD | -0.43% |
| 2003 Q2 | 1.61 Billion USD | 4.03% |
| 2002 Q2 | 1.41 Billion USD | 7.69% |
| 2002 Q3 | 1.51 Billion USD | 7.59% |
| 2002 Q4 | 1.55 Billion USD | 2.7% |
| 2002 FY | 1.55 Billion USD | 12.46% |
| 2002 Q1 | 1.3 Billion USD | -5.48% |
| 2001 Q1 | 1.18 Billion USD | -4.05% |
| 2001 Q4 | 1.38 Billion USD | 8.12% |
| 2001 FY | 1.38 Billion USD | 12.54% |
| 2001 Q3 | 1.28 Billion USD | 6.63% |
| 2001 Q2 | 1.2 Billion USD | 1.75% |
| 2000 Q3 | 1.18 Billion USD | 1.14% |
| 2000 Q4 | 1.23 Billion USD | 3.95% |
| 2000 Q1 | 1.17 Billion USD | -2.64% |
| 2000 Q2 | 1.17 Billion USD | -0.12% |
| 2000 FY | 1.23 Billion USD | 2.24% |
| 1999 FY | 1.2 Billion USD | 25.17% |
| 1999 Q4 | 1.2 Billion USD | 3.01% |
| 1999 Q3 | 1.16 Billion USD | 2.02% |
| 1999 Q2 | 1.14 Billion USD | 0.5% |
| 1999 Q1 | 1.14 Billion USD | 18.5% |
| 1998 Q1 | 759.1 Million USD | 2.42% |
| 1998 Q3 | 950.4 Million USD | 13.64% |
| 1998 Q4 | 962 Million USD | 1.22% |
| 1998 FY | 962 Million USD | 29.79% |
| 1998 Q2 | 836.3 Million USD | 10.17% |
| 1997 Q2 | 484.8 Million USD | 10.53% |
| 1997 FY | 741.2 Million USD | 59.78% |
| 1997 Q4 | 741.2 Million USD | 22.65% |
| 1997 Q1 | 438.6 Million USD | -5.45% |
| 1997 Q3 | 604.3 Million USD | 24.65% |
| 1996 Q4 | 463.9 Million USD | 6.89% |
| 1996 Q1 | 303.7 Million USD | 2.29% |
| 1996 Q2 | 414 Million USD | 36.32% |
| 1996 Q3 | 434 Million USD | 4.83% |
| 1996 FY | 463.9 Million USD | 56.25% |
| 1995 Q4 | 296.9 Million USD | 0.0% |
| 1995 FY | 296.9 Million USD | 56.26% |
| 1994 FY | 190 Million USD | 0.0% |
| 1994 Q4 | 190 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Phreesia, Inc. | 371.08 Million USD | -2749.212% |
| Accuray Incorporated | 468.62 Million USD | -2156.165% |
| Align Technology, Inc. | 6.08 Billion USD | -73.787% |
| Elevance Health Inc. | 108.92 Billion USD | 90.294% |
| AxoGen, Inc. | 196.82 Million USD | -5271.722% |
| Boston Scientific Corporation | 35.13 Billion USD | 69.908% |
| CVS Health Corporation | 249.72 Billion USD | 95.766% |
| Cardinal Health, Inc. | 45.12 Billion USD | 76.567% |
| Centene Corporation | 84.64 Billion USD | 87.508% |
| DaVita Inc. | 17.61 Billion USD | 39.993% |
| HCA Healthcare, Inc. | 56.21 Billion USD | 81.191% |
| Hologic, Inc. | 9.15 Billion USD | -15.476% |
| Humana Inc. | 47.06 Billion USD | 77.535% |
| IDEXX Laboratories, Inc. | 3.25 Billion USD | -224.333% |
| Laboratory Corporation of America Holdings | 16.72 Billion USD | 36.784% |
| Masimo Corporation | 3.04 Billion USD | -247.625% |
| McKesson Corporation | 67.44 Billion USD | 84.323% |
| Patterson Companies, Inc. | 2.96 Billion USD | -256.106% |
| Quest Diagnostics Incorporated | 14.02 Billion USD | 24.597% |
| ResMed Inc. | 6.87 Billion USD | -53.847% |
| Teladoc Health, Inc. | 4.39 Billion USD | -140.713% |
| Universal Health Services, Inc. | 14.35 Billion USD | 26.356% |
| Veeva Systems Inc. | 5.91 Billion USD | -78.872% |
| Baxter International Inc. | 28.27 Billion USD | 62.608% |
| Becton, Dickinson and Company | 52.78 Billion USD | 79.968% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | 31.529% |
| Danaher Corporation | 84.48 Billion USD | 87.486% |
| Stryker Corporation | 39.91 Billion USD | 73.509% |
| Medtronic plc | 89.98 Billion USD | 88.25% |